Editorial: Tumor microenvironment (TME) and tumor immune microenvironment (TIME): New perspectives for prognosis and therapy

• Rodrigo Nalio Ramos,
• Mariane Tami Amano,
• Adriana Franco Paes Leme,
• Jay Willian Fox,
• Ana Karina de Oliveira

Affiliations

Rodrigo Nalio Ramos

Departament of Hematology and Cell Therapy, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), D’Or Institute for Research and Education (IDOR), Hospital Das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Mariane Tami Amano

Hospital Sirio Libanes, São Paulo, Brazil

Adriana Franco Paes Leme

Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil

Jay Willian Fox

Department of Microbiology, Immunology and Cancer Biology, Office of Research Core Administration (ORCA), University of Virginia School of Medicine, Charlottesville, VA, United States

Ana Karina de Oliveira

Department of Pathology, University of Virginia School of Medicine, Spatial Biology Core (SBC) Facility, Charlottesville, VA, United States